# Perindopril

## Acertil 5mg

| TAH Drug Code      | [OACE5](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OACE5)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Hypertension Congestive heart failure In patients with a history of myocardial infarction and/or revascularization， when used in combination with conventional anti-anginal therapy， it can reduce the risk of cardiac events.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Dosing             | HTN Initial: 5 mg QD before meal， maximum 16mg/day CHF: Initial: 2.5 mg QD before meal slow titrate up， maximum to 8-16mg QD Stable coronary artery disease: Initial: 5 mg QD before meal for 2 weeks; titrate up to10 mg QD if needed.                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | Hypersensitivity to the active ingredient (perindopril)， any excipient， or other angiotensin-converting enzyme (ACE) inhibitors. History of angioedema related to ACE inhibitor therapy. Hereditary or idiopathic angioedema. Second and third trimesters of pregnancy. Concomitant use with Aliskiren-containing products in patients with diabetes or renal impairment (GFR < 60 ml/min/1.73 m2). Concomitant use with sacubitril/valsartan—do not initiate this medication within 36 hours of sacubitril/valsartan administration. Extracorporeal treatments leading to blood contact with negatively charged surfaces. Significant bilateral renal artery stenosis or stenosis of a solitary functioning kidney. |
| Adverse Effects    | GI disorders; dizziness， headaches， mood &/or sleep disorders， asthenia; taste disorder; cramps， localized rash; dry cough; angioneurotic edema. Gastrointestinal: Intestinal angioedema Hepatic: Liver failure (rare) Other: Angioedema， More frequent in black patients (0.1%)， Angioedema of lips， More frequent in black patients (0.1%)， Angioedema of throat， More frequent in black patients (0.1%)                                                                                                                                                                                                                                                                                                    |
| Pregnancy          | Human Data Suggest Risk in 2nd and 3rd Trimesters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| More Info          | [UpToDate](https://www.uptodate.com/contents/perindopril-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

